| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |